A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men

CONTEXT: A novel formulation of oral testosterone (T) undecanoate (TU) was evaluated in a phase 3 clinical trial. OBJECTIVE: Determine efficacy, short-term safety, and alignment of new oral TU formulation with current US approval standards for T replacement therapy. DESIGN: Randomized, active-contro...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Endocrinol Metab
Autori principali: Swerdloff, Ronald S, Wang, Christina, White, William B, Kaminetsky, Jed, Gittelman, Marc C, Longstreth, James A, Dudley, Robert E, Danoff, Theodore M
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Clinical Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7282712/
https://ncbi.nlm.nih.gov/pubmed/32382745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgaa238
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi